On Typing Amyloidosis Using Immunohistochemistry. Detailled Illustrations, Review and a Note on Mass Spectrometry

Reinhold P. Linke MD, PhD
{"title":"On Typing Amyloidosis Using Immunohistochemistry. Detailled Illustrations, Review and a Note on Mass Spectrometry","authors":"Reinhold P. Linke MD, PhD","doi":"10.1016/j.proghi.2012.03.001","DOIUrl":null,"url":null,"abstract":"<div><p>Every amyloid disease needs to be assessed for chemical composition of its amyloid because amyloid is pathogenetically diverse and each of the chemical amyloid types requires a different therapy. Basically four different approaches are being applied for typing of amyloid using immunohistochemistry, immunochemistry, mass spectrometry and chemistry. It is shown here how an easy immunohistochemical procedure has been developed over the years that can be used to classify specifically amyloid proteins for clinico-pathologic routine use. A larger number of tissues with chemically or immunochemically typed amyloids served as prototypes for developing a set of validated amyloid antibodies. These were examined for their performance to classify a larger number of tissues of patients submitted to us and other institutions allowing independent evaluation. The data reveal that out of 663 patients, including 15 different amyloid types, all 119 prototype Amyloids (100%) have been classified correctly and 97.9% of consecutive 581 unknown amyloid tissues submitted for typing to our laboratory of whom 37 became later prototypes. Twelve samples (2.1%) could not be classified. By using appropriate amyloid antibodies in a comparative manner, this procedure is accurate. It identifies the respective amyloid type and excludes simultaneously other amyloids. Its improved performance leads to an accurate amyloid diagnosis in most cases and provides a diagnostic marker which is independend of any other information for therapeutic considerations. These results can be obtained within a day in institutes competent in performing immunohistochemistry. This is the first report on immunhistochemical typing of amyloid providing detailed illustrations of the original results for training purposes. When the immunohistochemical method presented here was compared with mass spectrometry, a more recent method for amyloid typing, the advantages and failures of both methods became apparent in an international blinded comparison.</p></div>","PeriodicalId":54550,"journal":{"name":"Progress in Histochemistry and Cytochemistry","volume":"47 2","pages":"Pages 61-132"},"PeriodicalIF":0.0000,"publicationDate":"2012-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.proghi.2012.03.001","citationCount":"75","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Histochemistry and Cytochemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0079633612000186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 75

Abstract

Every amyloid disease needs to be assessed for chemical composition of its amyloid because amyloid is pathogenetically diverse and each of the chemical amyloid types requires a different therapy. Basically four different approaches are being applied for typing of amyloid using immunohistochemistry, immunochemistry, mass spectrometry and chemistry. It is shown here how an easy immunohistochemical procedure has been developed over the years that can be used to classify specifically amyloid proteins for clinico-pathologic routine use. A larger number of tissues with chemically or immunochemically typed amyloids served as prototypes for developing a set of validated amyloid antibodies. These were examined for their performance to classify a larger number of tissues of patients submitted to us and other institutions allowing independent evaluation. The data reveal that out of 663 patients, including 15 different amyloid types, all 119 prototype Amyloids (100%) have been classified correctly and 97.9% of consecutive 581 unknown amyloid tissues submitted for typing to our laboratory of whom 37 became later prototypes. Twelve samples (2.1%) could not be classified. By using appropriate amyloid antibodies in a comparative manner, this procedure is accurate. It identifies the respective amyloid type and excludes simultaneously other amyloids. Its improved performance leads to an accurate amyloid diagnosis in most cases and provides a diagnostic marker which is independend of any other information for therapeutic considerations. These results can be obtained within a day in institutes competent in performing immunohistochemistry. This is the first report on immunhistochemical typing of amyloid providing detailed illustrations of the original results for training purposes. When the immunohistochemical method presented here was compared with mass spectrometry, a more recent method for amyloid typing, the advantages and failures of both methods became apparent in an international blinded comparison.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
淀粉样变性的免疫组织化学分型研究。详细的插图,回顾和质谱注释
每种淀粉样蛋白疾病都需要评估其淀粉样蛋白的化学成分,因为淀粉样蛋白在病理上是多种多样的,每种化学淀粉样蛋白类型都需要不同的治疗方法。基本上有四种不同的方法被应用于淀粉样蛋白的分型:免疫组织化学、免疫化学、质谱和化学。这里展示了一种简单的免疫组织化学方法是如何在过去的几年里发展起来的,它可以用来对临床病理常规使用的淀粉样蛋白进行特异性分类。大量具有化学或免疫化学类型的淀粉样蛋白的组织作为开发一套有效的淀粉样抗体的原型。我们检查了它们对提交给我们和其他允许独立评估的机构的大量患者组织进行分类的性能。数据显示,在663例患者中,包括15种不同的淀粉样蛋白类型,所有119个原型淀粉样蛋白(100%)都被正确分类,连续581个未知的淀粉样蛋白组织中有97.9%提交给我们实验室分型,其中37个成为后来的原型。12个样本(2.1%)无法分类。通过以比较的方式使用适当的淀粉样抗体,该程序是准确的。它识别相应的淀粉样蛋白类型,同时排除其他淀粉样蛋白。在大多数情况下,其改进的性能导致准确的淀粉样蛋白诊断,并提供了一个独立于任何其他治疗考虑信息的诊断标记。这些结果可以在有能力进行免疫组织化学的机构一天内得到。这是第一份关于淀粉样蛋白免疫组织化学分型的报告,为培训提供了详细的原始结果说明。当本文提出的免疫组织化学方法与质谱法(一种最新的淀粉样蛋白分型方法)进行比较时,两种方法的优点和缺点在国际盲法比较中变得明显。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.67
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: Progress in Histochemistry and Cytochemistry publishes comprehensive and analytical reviews within the entire field of histochemistry and cytochemistry. Methodological contributions as well as papers in the fields of applied histo- and cytochemistry (e.g. cell biology, pathology, clinical disciplines) will be accepted.
期刊最新文献
Intracellular and extracellular microRNA: An update on localization and biological role Protein multiplicity can lead to misconduct in western blotting and misinterpretation of immunohistochemical staining results, creating much conflicting data ifc Editorial Board A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue L1CAM: Cell adhesion and more
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1